Satellos Bioscience Inc. Common Stock (MSLE)
Stock · NASDAQ · Health Care
$8.92as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$5.7
Industry
Biotechnology: Pharmaceutical Preparations
About MSLE
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidat…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 18
- Website
- satellos.com/
Fundamentals
- 1-day range
- $9.75$10.65
- Market cap
- $209.77M
- P/E (trailing)
- —
- P/E (forward)
- -3.59
- EPS (trailing)
- $-1.81
- Dividend yield
- —
- Beta
- 1.81
- Avg. volume
- 54.9K
52-week range
$7.08$18.98
Next earnings: November 12, 2026 · EPS estimate $-0.52confirmed
Forecasts
3 analyst ratings
Buy 91%
Hold 9%
Sell 0%
1-year price forecast
High
$40
+348.7%
Median
$23
+158.0%
Low
$20
+124.3%
Satellos Bioscience Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MSLESatellos Bioscience Inc. Common Stock$8.92▼ 7.23%Market cap $209.77MP/E —$7.08$18.98
- GLSIGreenwich LifeSciences Inc. Common Stock$15.67▼ 16.34%Market cap $209.02MP/E —$7.78$34.1
- NERVMinerva Neurosciences Inc Common Stock$4.85▼ 5.56%Market cap $206.85MP/E —$1.93$12.46
- NBPNovaBridge Biosciences American Depositary Shares$1.85▼ 2.38%Market cap $196.15MP/E —$1.46$6.79
- SIGASIGA Technologies Inc. Common Stock$3.07▲ 0.33%Market cap $223.78MP/E —$2.83$9.45
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$13.59▲ 0.18%Market cap $185.71MP/E —$9.4$33.22
- ACIUAC Immune SA Common Stock$2.67▼ 1.48%Market cap $236.11MP/E —$2.03$4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MSLE Satellos Bioscience Inc. Common Stock | $209.77M | — | $8.92 | ▼ 7.23% | $7.08$18.98 |
| GLSI Greenwich LifeSciences Inc. Common Stock | $209.02M | — | $15.67 | ▼ 16.34% | $7.78$34.1 |
| NERV Minerva Neurosciences Inc Common Stock | $206.85M | — | $4.85 | ▼ 5.56% | $1.93$12.46 |
| NBP NovaBridge Biosciences American Depositary Shares | $196.15M | — | $1.85 | ▼ 2.38% | $1.46$6.79 |
| SIGA SIGA Technologies Inc. Common Stock | $223.78M | — | $3.07 | ▲ 0.33% | $2.83$9.45 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $185.71M | — | $13.59 | ▲ 0.18% | $9.4$33.22 |
| ACIU AC Immune SA Common Stock | $236.11M | — | $2.67 | ▼ 1.48% | $2.03$4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price TargetBenzinga · 8/17/2026
- Satellos Bioscience Q2 EPS $(0.56) Misses $(0.45) EstimateBenzinga · 8/13/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 7.60M
- Total value held
- $42.62M
- Institutional holders
- 31
Top holders this quarter
- Unknown938.7K
- Unknown892.1K
- Unknown813.7K
- Unknown690.8K
- Unknown500.4K
- Unknown489.2K
- Unknown475.0K
- Unknown414.4K
- Unknown387.8K
- Unknown380.4K
See the full, filterable feed with live charts on the MarketWall dashboard.